Company

[ the science of genetics. the business of discovery. ]
+

Prehistory has happened before.
Bringing it back to life through bioscience hasn’t.

At Colossal Biosciences, we endeavor to jumpstart nature’s ancestral heartbeat. To see the Woolly Mammoth thunder upon the tundra once again. To advance the economies of biology and nutrition. To make humanity more human. And to reawaken the lost wilds of Earth. So we, and our planet, can breathe easier.

These things, which were not achievable before, are now. In our laboratories. Through our breakthroughs in CRISPR and genetic engineering.

We are leading the new charge of bioscience. We accept the responsibility. And we can see the light at the end of it all.

Many companies claim they're going to change the world.
At Colossal, we believe that the world doesn't need to be changed.

THE WORLD
NEEDS TO
BE HEALED.
+

Which is exactly what we're doing through purposeful advancements in science. Because when it comes to our planet, science is everything.

company
[ QUOTE ]

“In 2014, I asked my friend Elon Musk who he knew who was poised to make profound changes in the field of genomics, and he said: George Church.

So in June 2014, I visited George at his lab in Boston. I immediately knew I’d be looking for an opportunity to collaborate with George. Global Space Ventures is excited to be backing Colossal. George Church’s personal passion for the mission, combined with the stellar team assembled by serial entrepreneur Ben Lamm, is at the perfect intersection of audacious yet achievable. The path to de-extinction is now at hand, and leveraging CRISPR/Cas9 technology, to bring back extinct species and preserve those that we have, will have profound importance to humanity.”

Laetitia Garriott de Cayeux

Founder/CEO of Global Space Ventures

[ colossal investor ]

+
+
SOURCE
+
+
Cas9
mission + goal

MODERN BIOLOGY
BUILT UPON THE PAST.

MISSION

Through technological and engineering breakthroughs in biosciences and genetics, Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition.

GOAL

Colossal will revolutionize history and be the first company to use CRISPR technology successfully in the de-extinction of previously lost species. On the journey we will build radical new software tools and technologies to advance the science of genomics overall.

[ QUOTE ]

"I've followed the ground-breaking work of George Church for years. I have also invested in and coached Ben Lamm when he founded Hypergiant. These two are a powerhouse team who have the ability to completely shift our understanding of modern genetics while developing innovative technologies that not only help bring back lost species, but advance the entire industry. I am proud to be an investor in their journey."

Tony Robbins

World Famous Life-Coach, Author,
Investor and Entrepreneur

[ colossal investor ]

SECTION 05

core
values

COLOSSAL
LABS & SYSTEMS
Duty to Preserve & Protect a Pristine Nature
+

As grateful citizens of the universe, we recognize the value of habitable environments for our species and those around us. As tenants of Earth, currently the only livable planet in our solar system, it is not enough just to be grateful, but we must also be active in a role as custodians and defenders of the nature which sustains life.

RESPECT FOR ALL LIVING THINGS
+

Balance is not for us to determine. It has been refined for billions and billions of years by forces such as gravity, geology and evolution. Thus it is not our role to pick and choose the winners and losers. But merely to respect all living things - past and present.

Pushing the Humanistic & Economic Potential of Bioscience
+

Today, the Woolly Mammoth. But tomorrow, maybe the cure for blindness, eradication of tumors and elimination of disease. The potential of bioscience is almost unlimited, and we are at the forefront, pushing the boundaries.

Virtue & Moral Good
+

At Colossal we are driven by the forces of virtue and moral good - working for a healthier planet, a healthier human populace and a pursuit of that which we recognize as goodness, compassion and honest, pure science.

+

Colossal’s
Values &
Commitments

Colossal expands the boundaries of what is possible with CRISPR and other cutting edge biological engineering technologies, always with a commitment to responsible science and stewardship of our planet’s natural diversity. We are guided by these values:

[ Unbreakable PRINCIPLES ]

+
01
Thoughtful Innovation
+
  • Horizon scanning
  • Questioning traditional approaches
  • Creative solutions
  • Careful designs
02
Excellence & Integrity
+
  • Rigorous methodology
  • Unbiased analysis
  • Careful risk-benefit analysis
  • Transparency
03
Responsible Science
+
  • End-to-end biosafety and biosecurity measures
  • Integrated monitoring and mitigation tools
  • Fair distribution of risks and benefits
04
Equity & Sustainability
+
  • Ecosystem stability
  • Economic viability
  • Broad accessibility by design
  • Intergenerational justice
05
Inclusiveness
+
  • Community engagement
  • Respect for cultural viewpoints
  • Diverse workforce development
  • Global viewpoint
[ QUOTE ]

"Healing our Earth's ecosystems is of critical planetary importance.

The overwhelming success of the human species has come at a profound price, the massive global loss of biodiversity and destruction of basic ecological services that have been tuned over millions of years to support life. Colossal is pioneering an approach to ecosystem restoration and bioscience innovation that can help reverse this trend, restoring some balance to the world."

Zack Lynch
+

Managing Partner JAZZ Ventures, founder & CEO of NeuroInsights, best-selling author, founder of Neurotechnology Industry Organization, creator of Experiential Technology and NeuroGaming Conference and Expo

[ Colossal Investor ]

 

Company

leadership

+

It will be up to humans to reverse the harm caused by humans. Hence, our team is intentionally selected to accomplish exactly that - comprised of world-leaders in science and genetics to ecology and industry.

+
REF 0004
founders of colossal

FOUNDER

ben lamm

+ BIO

Ben Lamm is the co-founder and CEO of Colossal. Ben is a serial technology entrepreneur driven to solve the most complex challenges facing our planet. For over a decade, Ben has built disruptive businesses that future-proof our world. In addition to leading and growing his own companies, he is passionate about emerging technology, science, space and climate change. Active in angel investing, incubators and startup communities, Ben invests in software and emerging tech, and is deeply engaged in the technology, defense and climate change communities.

Prior to Colossal, Ben served as the founder and CEO to a number of companies, including Hypergiant, an enterprise AI software company focused on critical infrastructures, space, and defense; Conversable, the leading conversational intelligence platform that helps brands reach customers through automated experiences acquired by LivePerson; and Chaotic Moon, a global creative technology powerhouse acquired by Accenture. Ben was also the co-founder of Team Chaos, a consumer gaming company acquired by Zynga.

Ben is a fellow of the Explorer’s Club, whose mission is to promote the scientific exploration of land, sea, air, and space by supporting research and education in the physical, natural and biological sciences. He also serves as a Scientific Advisory Board member on the Planetary Society and sits on the Advisory Board for the Arch Mission. Ben has appeared as a thought leader in many publications, including the Wall Street Journal, New York Times, Forbes, Entrepreneur, Wired, TechCrunch, VentureBeat, and Newsweek on topics such as innovation, technology and entrepreneurship.

FOUNDER

George Church, PH.D.

+ BIO

George Church, Ph.D. acts as the co-founder and genetics lead advisor for Colossal. Additionally he serves as the head of the Wyss Institute, while also independently running Church Labs at Harvard. Currently also a professor at Harvard and MIT, Church is the recognized leader in genomics, pioneering a number of advances and breakthroughs that have progressed the entire field of genomics.

In 1984 with Wally Gilbert, Church developed the first direct genomic sequencing method and barcode-multiplexing tags. This led to automation and software used for the first cellular genome sequence (Helicobacter) in 1994, which evolved into ‘in-situ sequencing’ (1999) and ‘next-generation sequencing’ (2014).

Church then pioneered chip-based DNA libraries, genome editing, and stem cell engineering. He also pioneered new privacy, biosafety, human engineering, environmental, biosecurity, and bioethics strategies and training. Today, he and his group champion open-access human genome data.

For his achievements and direct contributions to genomics and the sciences as a whole, Church has received numerous awards. Some of his most prestigious recognitions include National Academy of Sciences, National Academy of Engineering, the Heptannual Bower Award, and Prize for Achievement in Science from the Franklin Institute.

Leadership

EXECUTIVE CORE

+
+
ANDREW BUSEY
CO-FOUNDER, CHIEF PRODUCT OFFICER
+
ERIONA HYSOLLI, Ph.D.
HEAD OF BIOLOGICAL SCIENCES
+
KENT WAKEFORD
CO-FOUNDER, CHIEF OPERATING OFFICER
+
BRANDI CANTAREL, Ph.D.
ASSOCIATE DIRECTOR OF BIOINFORMATICS
+
PETER PHILLIPS
CO-FOUNDER, CHIEF BUSINESS OFFICER
+
BRIAN BEARD
CO-FOUNDER, CHIEF LEGAL OFFICER
+
SARA ORD
ASSOCIATE DIRECTOR OF Species Restoration

Leadership

SCIENTIFIC
ADVISORY BOARD

+
Section 09

At Colossal we're bringing together the greatest minds and leaders in technology, translational medicine, chemical engineering, biotechnology, molecular genetics, and software along with ground breaking entrepreneurs to help guide us on our path. Our team includes practicing physicians, researchers, authors, inventors, professors, and winners of the Anitschkow Prize, National Medal of Technology and Innovation, Breakthrough Prize in Life Sciences and the Harvey Prize.

Company

EXECUTIVE
ADVISORY BOARD

+

We’re also partnering with leaders in critical industry sectors who have deep experience and decades of relationships with Fortune 500 leaders and beyond. This board ensures that we ethically meet our business objectives so our research and development into biosciences can continue to benefit humankind indefinitely.

Leadership
Section 11

ALLIED WITH
OTHERS WORKING
TO HEAL THE WORLD.

CRISPR-Cas9
Systems
+
THOMAS TULL

Billionaire film producer & entrepreneur, founder & CEO of Tulco, founder & former CEO of Legendary Entertainment

[ Colossal Investor ]

“I’m very excited to invest in Ben and George's new company, Colossal,”

said lead investor Thomas Tull.

“The platform they are building will have a meaningful impact on both ecology and cutting-edge biotechnology.”

COLOSSAL
INVESTORS

+

We’re proudly partnered with some of the greatest teams and organizations from around the globe. Each equally committed to our vision and shared objectives of restoring the world to a healthier state, de-extinction, preventing, or staving off extinction, and protecting all wildlife in general.

Thomas Tull is founder and CEO of Tulco, a privately held holding company that partners with entrepreneurial companies posed to transform old-line industries using cutting-edge technology. Tull is the founder and former CEO of the well-known film production company Legendary Entertainment

Draper Associates, founded in 1985, is a seed-stage venture capital firm that helps entrepreneurs to drive their businesses to greatness.

At One Ventures finds, funds, and grows teams to catalyze a world where humanity is a net positive to nature.

JAZZ Venture Partners invests in companies that extend the boundaries of human performance — improving how we live, learn, work, play, and experience the world.

The first venture firm with access to 100M+ engaged consumers across the world Driving growth by leveraging proprietary marketing channels and increasing consumer awareness.

GSV supports and partners with exceptional founders and entrepreneurs who push the boundaries of possibility and harness the power of science and technology to build better futures at scale.

Climate Capital invests alongside Tier 1 Seed investors into companies directly or indirectly chipping away at greenhouse gas emissions, or helping with adaptation.

Winklevoss Capital supports determined entrepreneurs by providing guidance, relationships and capital, helping to reinforce their pursuit of a frictionless world and a better human experience.

A capital-multiplying partnership that propels ethically-grounded visionaries who bring into life breakthrough ideas that advance well-being, and strengthen the integrity of the relationships between humans and the interconnected planet that supports them.

Conserve & Protect :

COMPANY CULTURE

+

The team at Colossal is committed, colorful, passionate, intelligent, collaborative, creative, experienced, scientific and world-class. That sounds like a lot to fit into one building. That’s why we are spread out in three locations that include laboratories, test facilities, academic institutions, libraries and offices.

Through it all, however, we maintain a culture of positivity, hope, happiness and belief that we’re doing something big. Something Colossal.

company culture
LOCATIONS MAP

Locations

Dallas
Texas
Austin
Texas
Boston
massachusetts